Interferon Beta-1b in Combination With Azathioprine for Secondary Progressive Multiple Sclerosis
PRAGUE, CZECH REPUBLIC –
The addition of azathioprine to standard treatment with ... more »
|
|||
|
Multiple Sclerosis Info
Search
This Month
|
Friday, November 30
Interferon Beta-1b in Combination With Azathioprine for Secondary Progressive Multiple Sclerosis
by
All About MS
on Fri 30 Nov 2007 07:02 AM CST
Locomotor training using body weight support on a treadmill improves mobility
by
All About MS
on Fri 30 Nov 2007 12:00 AM CST
Locomotor training using body weight support on a treadmill improves mobility in persons with multiple sclerosis: a pilot study. UCLA School of ... more » Thursday, November 29
Treatment of active secondary progressive multiple sclerosis with treosulfan
by
All About MS
on Thu 29 Nov 2007 12:00 AM CST
Treatment of active secondary progressive multiple sclerosis with treosulfan. University of Wuerzburg, Wuerzburg, Germany,
To study the safety and ... more » Tuesday, November 27
Alemtuzumab Reduces Relapses, Prevents Accumulation of Disability Compared With Standard Therapy
by
All About MS
on Tue 27 Nov 2007 12:00 AM CST
Alemtuzumab Reduces Relapses, Prevents Accumulation of Disability Compared With Standard Therapy: Presented at ECTRIMS PRAGUE, CZECH REPUBLIC Early treatment with alemtuzumab -- a ... more » Monday, November 26
Gene Logic Discovers Gene Expression Patterns for MS
by
All About MS
on Mon 26 Nov 2007 04:00 PM CST
Gene Logic Discovers Gene Expression Patterns for MS
Glucosamine may provide relief to patients with MS
by
All About MS
on Mon 26 Nov 2007 10:28 AM CST
Using a mouse model of Multiple Sclerosis (MS) in an animal study, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. In ... more » Sunday, November 25
Smoking Has No Effect on Progression of Multiple Sclerosis
by
All About MS
on Sun 25 Nov 2007 12:00 AM CST
Smoking Has No Effect on Progression of Multiple Sclerosis ST. PAUL, MN, USA – Contrary to an earlier report, smoking appears to ... more »
Cyclophosphamide Reduces Long-Term Brain Atrophy in Refractory Relapsing-Remitting Multiple
by
All About MS
on Sun 25 Nov 2007 12:00 AM CST
Short-Term Exposure to Cyclophosphamide Reduces Long-Term Brain Atrophy in Refractory Relapsing-Remitting Multiple Sclerosis: Presented at ECTRIMS By Chris Berrie PRAGUE, CZECH REPUBLIC – ... more » Saturday, November 24
Stem Cell Transplantation for Aggressive Multiple Sclerosis
by
All About MS
on Sat 24 Nov 2007 09:00 AM CST
Immune Ablation and Autologous Stem Cell Transplantation for Aggressive Multiple Sclerosis: Presented at ECTRIMS By Chris Berrie PRAGUE, CZECH REPUBLIC Immunoablative therapy ... more »
Phase II Spasticity Trial in Patients with Multiple Sclerosis
by
All About MS
on Sat 24 Nov 2007 02:00 AM CST
Avigen Initiates European Multi-Center AV650 Phase II Spasticity Trial in Patients with Multiple Sclerosis
Cell transplant hope for blood diseases
by
All About MS
on Sat 24 Nov 2007 12:00 AM CST
Cell transplant hope for blood diseases
"Bone marrow transplantation has been used for sickle cell anaemia with good results in children, but ... more » Wednesday, November 21
study for oral treatment of RRMS
by
All About MS
on Wed 21 Nov 2007 11:09 AM CST
Medical News Today
Small Molecule Compound Being Studied For The Treatment Of Relapsing-Remitting Multiple Sclerosis Monday, November 19
Apitope vaccine stops MS in its tracks
by
All About MS
on Mon 19 Nov 2007 08:01 AM CST
UK biopharmaceutical firm Apitope has developed a vaccine that could halt multiple sclerosis in its relentless march to destroy nerve cells. The drug, called ... more » Sunday, November 18
The importance of long-term data in MS
by
All About MS
on Sun 18 Nov 2007 08:34 AM CST
The importance of long-term data in multiple sclerosis. Wednesday, November 14
MR Imaging Intensity Modeling of Damage and Repair In MS
by
All About MS
on Wed 14 Nov 2007 10:00 AM CST
BRAIN MR Imaging Intensity Modeling of Damage and Repair In Multiple Sclerosis: Relationship of Short-Term Lesion Recovery to Progression and Disability a Department ... more » |
||